Which test provides appropriate lab confirmation of immune mediated heparin induced thrombocytopenia (type 2)?

Which test provides appropriate lab confirmation of immune mediated heparin induced thrombocytopenia (type 2)?

• A. Anti-PF3 antibody
• B. Ristocetin induced platelet aggregation assay
• C. Serotonin Release Assay
• D. Reptilase assay

Answer: (C)

When diagnosing immune-mediated HIT type 2, you need a test that shows the patient’s antibodies actually activating platelets in the presence of heparin. The serotonin release assay does this functional check: donor platelets are exposed to the patient’s serum and heparin, and if HIT antibodies are present, they trigger platelet activation and release of serotonin, which is measured. This functional demonstration makes the serotonin release assay a highly specific confirmatory test for HIT. Antibodies to the PF4-heparin complex detected by an immunoassay can be positive even in people without clinically significant HIT, so that test serves more as a screening tool rather than definitive confirmation. The ristocetin-induced platelet aggregation test evaluates platelet function related to von Willebrand factor and GP Ib, not the specific immune mechanism of HIT. The reptilase time isn’t used to confirm HIT at all; it’s relevant to other coagulation assessments and is not a HIT-specific test. So the serotonin release assay is the best choice for confirming immune-mediated HIT.

When diagnosing immune-mediated HIT type 2, you need a test that shows the patient’s antibodies actually activating platelets in the presence of heparin. The serotonin release assay does this functional check: donor platelets are exposed to the patient’s serum and heparin, and if HIT antibodies are present, they trigger platelet activation and release of serotonin, which is measured. This functional demonstration makes the serotonin release assay a highly specific confirmatory test for HIT.

Antibodies to the PF4-heparin complex detected by an immunoassay can be positive even in people without clinically significant HIT, so that test serves more as a screening tool rather than definitive confirmation. The ristocetin-induced platelet aggregation test evaluates platelet function related to von Willebrand factor and GP Ib, not the specific immune mechanism of HIT. The reptilase time isn’t used to confirm HIT at all; it’s relevant to other coagulation assessments and is not a HIT-specific test.

So the serotonin release assay is the best choice for confirming immune-mediated HIT.